Drug Trial Radar · NCT06523101
A Study of PJ009 in Healthy Adult Volunteers
Last checked: Nov 19, 2026Latest source record: Jul 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Feb 28, 2023
Primary completion
May 15, 2023
Study completion May 15, 2023
Sponsor
- Lead sponsor
- Chongqing Peg-Bio Biopharm Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The main aim of this clinical trial is to assess the safety of PJ009 in healthy adult volunteers aged 18-45. The main questions it aims to answer are: * Is PJ009 safe in healthy adult? Participants will * Receive single dose of PJ009 or placebo according to weight, and then multiple doses daily for 7 days, * Stay in hospital for assessment.
Conditions
- Short Bowel Syndrome
Interventions
PJ009Drug
Six participants in each dose level will be randomized to receive a single dose and/or multiple doses of PJ009 in a double-blind fashion.
PlaceboDrug
Two participants in each dose level will be randomized to receive placebo in a double-blind fashion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment-related Adverse EventsTime frame: Up to 18 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Second Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.